OGDHL and pancreatic neoplasm: MiR-193 a-5p regulates oxoglutarate dehydrogenase-like (OGDHL) and extracellular matrix protein 1 (ECM 1) alternative splicing by targeting SRSF 6, which triggers epithelial-mesenchymal transition (EMT) and consequently enhances pancreatic cancer progression (Li et al., 2020).